Zymosense develops novel probes for onsite and throughput enzyme measurement.
Zymosense's investors include National Science Foundation, Iowa G2M Accelerator.
Zymosense is headquartered in Ames, United States.
Zymosense develops novel probes for onsite and throughput enzyme measurement.
Zymosense is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Zymosense — Funding & Investors." VCBacked, June 29, 2022, https://www.vcbacked.co/company/zymosense. Accessed November 4, 2026.
VCBacked. (2022). Zymosense — Funding & Investors. Retrieved November 4, 2026, from https://www.vcbacked.co/company/zymosense
{{cite web |title=Zymosense — Funding & Investors |url=https://www.vcbacked.co/company/zymosense |website=VCBacked |access-date=November 4, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Zymosense? Request a listing update